Chen H-Y, Kao T-W, Huang J-W, Tsai T-J, Wu K-D
Department of Internal Medicine, Division of Nephrology, Far Eastern Memorial Hospital, Tapei, Taiwan.
Clin Nephrol. 2008 Sep;70(3):233-9. doi: 10.5414/cnp70233.
Dyslipidemia and residual renal function (RRF) have a significant impact on the cardiovascular mortality in dialysis patients, but their association in patients on chronic peritoneal dialysis (PD) has not been completely studied.
170 PD patients were divided into 2 groups based on the RRF (Group I had no RRF and Group II had RRF >0 ml/min/1.73 m2 BSA). An observational, longitudinal study was performed to elucidate the dyslipidemic state in PD patients with different levels of RRF and the association of dyslipidemia and deterioration of RRF during 3 years.
Patients' basic characteristics and lipid profiles at the initiation of study were similar between the groups. At the end of study, Group I patients had a lower T-CHO (p=0.001), LDL-C (p=0.018), HDL-C (p=0.05) and non-HDL-C (p=0.003) than Group II. There was a significant correlation between a change in HDL-C and the decline of RRF (r=0.177, p=0.048) and it was independent of PD duration and levels of highly sensitive C-reactive protein (r=0.233, p=0.04).
Our results clearly demonstrate the different longitudinal changes of lipid profiles in PD patients with different RRF and an association between decline of HDL-C and deterioration of RRF.
血脂异常和残余肾功能(RRF)对透析患者的心血管死亡率有重大影响,但它们在慢性腹膜透析(PD)患者中的关联尚未得到充分研究。
170例PD患者根据RRF分为两组(I组无RRF,II组RRF>0 ml/min/1.73 m2体表面积)。进行了一项观察性纵向研究,以阐明不同RRF水平的PD患者的血脂异常状态以及3年内血脂异常与RRF恶化之间的关联。
两组患者在研究开始时的基本特征和血脂谱相似。在研究结束时,I组患者的总胆固醇(T-CHO,p=0.001)、低密度脂蛋白胆固醇(LDL-C,p=0.018)、高密度脂蛋白胆固醇(HDL-C,p=0.05)和非高密度脂蛋白胆固醇(p=0.003)均低于II组。HDL-C的变化与RRF的下降之间存在显著相关性(r=0.177,p=0.048),且独立于PD持续时间和高敏C反应蛋白水平(r=0.233,p=0.04)。
我们的结果清楚地表明,不同RRF的PD患者血脂谱的纵向变化不同,且HDL-C下降与RRF恶化之间存在关联。